NextPlat (NXPL) Intangibles (2015 - 2026)
NextPlat's (NXPL) quarterly Intangibles came in at $371000.0 in Q2 2026, down 56.35% year-over-year from $850000.0 in Q2 2025, and down 12.09% quarter-over-quarter from $422000.0 in Q4 2025.
Powered by 
Analysis
NextPlat (NXPL) Intangibles (2015 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Intangibles for 12 consecutive years, with $371000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Intangibles fell 56.35% year-over-year to $371000.0 in Q2 2026; TTM through Jun 2026 was $371000.0, a 56.35% decrease from a year earlier, with the FY2025 full-year figure at $422000.0, down 50.35% from the prior year.
- Intangibles was $371000.0 for Q2 2026 at NextPlat, down from $422000.0 in the prior quarter.
- Over five years, Intangibles peaked at $16.0 million in Q4 2023 and troughed at $37500.0 in Q2 2023.
- A 5-year average of $3.1 million and a median of $600000.0 in 2024 frame the typical range for Intangibles.
- The widest YoY moves for Intangibles: up 36380.0% in 2024, down 95.75% in 2024.
- Over 5 years, Intangibles stood at $250000.0 in 2022, then jumped by 6284.0% to $16.0 million in 2023, then slumped by 94.67% to $850000.0 in 2024, then tumbled by 50.35% to $422000.0 in 2025, then declined by 12.09% to $371000.0 in 2026.
- The last three Intangibles figures came in at $371000.0 (Q2 2026), $422000.0 (Q4 2025), and $850000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 3.45 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 13.68 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 1.09 Bn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 587.83 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 4.18 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 449.86 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 142.48 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 29.23 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 371,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 371,000.00 |
| Dec 31, 2025 | 422,000.00 |
| Sep 30, 2025 | 850,000.00 |
| Jun 30, 2025 | 850,000.00 |
| Mar 31, 2025 | 850,000.00 |
| Dec 31, 2024 | 850,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Jun 30, 2024 | 600,000.00 |
| Mar 31, 2024 | 15.96 Mn |
| Dec 31, 2023 | 15.96 Mn |
| Sep 30, 2023 | 14.12 Mn |
| Jun 30, 2023 | 37,500.00 |
| Mar 31, 2023 | 43,750.00 |
| Dec 31, 2022 | 250,000.00 |
| Sep 30, 2022 | 56,250.00 |
| Jun 30, 2022 | 62,500.00 |
| Mar 31, 2022 | 68,750.00 |
| Dec 31, 2021 | 75,000.00 |
| Sep 30, 2021 | 81,250.00 |
| Jun 30, 2021 | 87,500.00 |